Novel technology to study Co-evolution of humans and staphylococcus aureus: Consequences for interpreting the biology of colonisation and infection

Advances in Experimental Medicine and Biology

Volumn 697, Issue , 2011, Pages 273-288

  Van Belkum, Alex ^a  

^a BIOMÉRIEUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CHLORHEXIDINE; PSEUDOMONIC ACID;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIUM CARRIER; BIOASSAY; COEVOLUTION; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; HOST PATHOGEN INTERACTION; HOST RANGE; HOST SUSCEPTIBILITY; HUMAN; HUMORAL IMMUNITY; IMMUNE STATUS; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPECIES HABITAT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; DISEASE TRANSMISSION; GENETICS; GENOMICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; MICROBIOLOGY; MOLECULAR EVOLUTION; REVIEW;

ANTIBODIES, BACTERIAL; EVOLUTION, MOLECULAR; GENOMICS; HOST-PATHOGEN INTERACTIONS; HUMANS; MICROBIOLOGY; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 79952279159     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-7185-2_19     Document Type: Article

References (64)

1. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997 Jul;10(3):505-20.
2. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, Nouwen JL. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005 Dec;5(12):751-62.
3. van Belkum A, Melles DC, Peeters JK, van Leeuwen WB, van Duijkeren E, Huijsdens XW, Spalburg E, de Neeling AJ, Verbrugh HA. Dutch working party on surveillance and research of MRSA-SOM. methicillin-resistant and -susceptible Staphylococcus aureus sequence type 398 in pigs and humans. Emerg Infect Dis. 2008 Mar;14(3):479-83.
4. van Leeuwen WB, Melles DC, Alaidan A, Al-Ahdal M, Boelens HA, Snijders SV, Wertheim H, van Duijkeren E, Peeters JK, van der Spek PJ, Gorkink R, Simons G, Verbrugh HA, van Belkum A. Host- and tissue-specific pathogenic traits of Staphylococcus aureus. J Bacteriol. 2005 Jul;187(13):4584-91.
5. Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, van Keulen PH, Vandenbroucke-Grauls CM, Meester MH, Verbrugh HA. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet. 2004 Aug 21-27;364(9435):703-5.
6. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med. 2001 Jan 4;344(1): 11-16.
7. van Belkum A. Staphylococcal colonization and infection: homeostasis versus disbalance of human (innate) immunity and bacterial virulence. Curr Opin Infect Dis. 2006 Aug;19(4): 339-44.
8. van Belkum A, Melles DC, Nouwen J, van Leeuwen WB, van Wamel W, Vos MC, Wertheim HF, Verbrugh HA. Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus. Infect Genet Evol. 2009 Jan;9(1):32-47.
9. Koyama T, Yamada M, MatsuhashiM. Formation of regular packets of Staphylococcus aureus cells. J Bacteriol. 1977 Mar;129(3):1518-23.
10. Bruins MJ, Juffer P, Wolfhagen MJ, Ruijs GJ. Salt tolerance of methicillin-resistant and methicillin-susceptible Staphylococcus aureus. J Clin Microbiol. 2007 Feb;45(2):682-3.
11. Bergeron MG. Revolutionizing the practice of medicine through rapid (<1 h) DNA-based diagnostics. Clin Invest Med 2008 Oct 1; 31(5):E265-E71
12. van Belkum A, Niesters HG, MacKay WG, van Leeuwen WB. Quality control of direct molecular diagnostics for methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2007 Aug;45(8):2698-700.
13. Hota B. Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection?. Clin Infect Dis. 2004 Oct 15;39(8):1182-9.
14. Siebert U, Müller G, Desportes G, Weiss R, Hansen K, Baumgärtner W. Pyogranulomatous myocarditis due to Staphylococcus aureus septicaemia in two harbour porpoises (Phocoena phocoena). Vet Rec. 2002 Mar 2;150(9):273-7.
15. Patti JM, House-Pompeo K, Boles JO, Garza N, Gurusiddappa S, Hük M. Critical residues in the ligand-binding site of the Staphylococcus aureus collagen-binding adhesin (MSCRAMM). J Biol Chem. 1995 May 19;270(20):12005-11.
16. Tsuru T, Kawai M, Mizutani-Ui Y, Uchiyama I, Kobayashi I. Evolution of paralogous genes: reconstruction of genome rearrangements through comparison of multiple genomes within Staphylococcus aureus. Mol Biol Evol. 2006 Jun;23(6):1269-85.
17. Lindsay JA, Moore CE, Day NP, Peacock SJ, Witney AA, Stabler RA, Husain SE, Butcher PD, Hinds J. Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes. J Bacteriol. 2006 Jan;188(2):669-76.
18. Ito T, Katayama Y, Asada K, Mori N, Tsutsumimoto K, Tiensasitorn C, Hiramatsu K. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2001 May;45(5):1323-36.
19. Melles DC, Gorkink RF, Boelens HA, Snijders SV, Peeters JK, Moorhouse MJ, van der Spek PJ, van Leeuwen WB, Simons G, Verbrugh HA, van Belkum A. Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J Clin Invest. 2004 Dec;114(12):1732-40.
20. Melles DC, Tenover FC, Kuehnert MJ, Witsenboer H, Peeters JK, Verbrugh HA, van Belkum A. Overlapping population structures of nasal isolates of Staphylococcus aureus from healthy Dutch and American individuals. J Clin Microbiol. 2008 Jan;46(1):235-41.
21. Wertheim HF, van Leeuwen WB, Snijders S, Vos MC, Voss A, Vandenbroucke-Grauls CM, Kluytmans JA, Verbrugh HA, van Belkum A. Associations between Staphylococcus aureus genotype, infection, and in-hospital mortality: a nested case-control study. J Infect Dis. 2005 Oct 1;192(7):1196-200.
22. Lina G, Boutite F, Tristan A, BesM, Etienne J, Vandenesch F. Bacterial competition for human nasal cavity colonization: role of Staphylococcal agr alleles. Appl Environ Microbiol. 2003 Jan;69(1):18-23.
23. Acton DS, Plat-Sinnige MJ, van Wamel W, de Groot N, van Belkum A. Intestinal carriage of Staphylococcus aureus: how does its frequency compare with that of nasal carriage and what is its clinical impact?. Eur J Clin Microbiol Infect Dis. 2009 Feb;28(2):115-27.
24. Nouwen JL, Ott A, Kluytmans-Vandenbergh MF, Boelens HA, Hofman A, van Belkum A, Verbrugh HA. Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a "culture rule". Clin Infect Dis. 2004B Sep 15;39(6):806-11.
25. Sewell CM, Clarridge J, Lacke C, Weinman EJ, Young EJ. Staphylococcal nasal carriage and subsequent infection in peritoneal dialysis patients. JAMA. 1982 Sep 24;248(12): 1493-5.
26. VandenBergh MF, Yzerman EP, van Belkum A, Boelens HA, Sijmons M, Verbrugh HA. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J Clin Microbiol. 1999 Oct;37(10):3133-40.
27. Kinsman OS, McKenna R, Noble WC. Association between histocompatability antigens (HLA) and nasal carriage of Staphylococcus aureus. J Med Microbiol. 1983 May;16(2): 215-20.
28. Gillespie WJ, Haywood-Farmer M, Fong R, Harding SM. Aspects of the microbe: host relationship in staphylococcal hematogenous osteomyelitis. Orthopedics. 1987 Mar;10(3): 475-80.
29. Montagnac R, Eloy C, Schillinger F, Croix JC, Milcent T. Repeated studies of the prevalence of Staphylococcus aureus in the nasal cavity in hemodialysed patients. Presse Med. 1995 Jun 24;24(23):1075-7.
30. Tabarya D, Hoffman WL. Staphylococcus aureus nasal carriage in rheumatoid arthritis: antibody response to toxic shock syndrome toxin-1. Ann Rheum Dis. 1996 Nov;55(11): 823-8.
31. Kozio-Montewka M, Chudnicka A, Ksiazek A, Majdan M. Rate of Staphylococcus aureus nasal carriage in immunocompromised patients receiving haemodialysis treatment. Int J Antimicrob Agents. 2001 Aug;18(2):193-6.
32. Laki J, Laki I, Németh K, Ujhelyi R, Bede O, Endreffy E, Bolbás K, Gyurkovits K, Csiszér E, Sólyom E, Dobra G, Halász A, Pozsonyi E, Rajczy K, Prohászka Z, Fekete G, Füst G. The 8.1 ancestral MHC haplotype is associated with delayed onset of colonization in cystic fibrosis. Int Immunol. 2006 Nov;18(11):1585-90. Epub 2006 Sep 20.
33. Emonts M, de Jongh CE, Houwing-Duistermaat JJ, van Leeuwen WB, de Groot R, Verbrugh HA, Hermans PW, van Belkum A. Association between nasal carriage of Staphylococcus aureus and the human complement cascade activator serine protease C1 inhibitor (C1INH) valine vs. methionine polymorphism at amino acid position 480. FEMS Immunol Med Microbiol. 2007 Aug;50(3):330-2.
34. Emonts M, Uitterlinden AG, Nouwen JL, Kardys I, Maat MP, Melles DC, Witteman J, Jong PT, Verbrugh HA, Hofman A, Hermans PW, Belkum A. Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J Infect Dis. 2008 May 1;197(9): 1244-53.
35. van den Akker EL, Nouwen JL, Melles DC, van Rossum EF, Koper JW, Uitterlinden AG, Hofman A, Verbrugh HA, Pols HA, Lamberts SW, van Belkum A. Staphylococcus aureus nasal carriage is associated with glucocorticoid receptor gene polymorphisms. J Infect Dis 2006 Sep 15;194(6):814-18.
36. van Belkum A, Emonts M, Wertheim H, de Jongh C, Nouwen J, Bartels H, Cole A, Cole A, Hermans P, Boelens H, Toom NL, Snijders S, Verbrugh H, van LeeuwenW. The role of human innate immune factors in nasal colonization by Staphylococcus aureus. Microbes Infect. 2007 Oct;9(12-13):1471-7.
37. Nouwen J, Boelens H, van Belkum A, Verbrugh H. Human factor in Staphylococcus aureus nasal carriage. Infect Immun. 2004A Nov;72(11):6685-8.
38. Koning S, van Belkum A, Snijders S, van Leeuwen W, Verbrugh H, Nouwen J, Op 't Veld M, van Suijlekom-Smit LW, van der Wouden JC, Verduin C. Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton-Valentine leukocidin, and the multidrug resistance plasmid pSK41. J Clin Microbiol. 2003 Jul;41(7):3017-21.
39. van Rijen MM, Bonten M, Wenzel RP, Kluytmans JA. Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. J Antimicrob Chemother. 2008 Feb;61(2):254-61.
40. Wertheim HF, Walsh E, Choudhurry R, Melles DC, Boelens HA, Miajlovic H, Verbrugh HA, Foster T, van Belkum A. Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans. PLoS Med. 2008 Jan 15;5(1):e17.
41. van Belkum A, Verkaik NJ, de Vogel CP, Boelens HA, Verveer J, Nouwen JL, Verbrugh HA, Wertheim HF. Reclassification of Staphylococcus aureus nasal carriage types. J Infect Dis. 2009 Jun 15;199(12):1820-6.
42. Corrigan RM, Rigby D, Handley P, Foster TJ. The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation. Microbiology. 2007 Aug;153(Pt 8): 2435-46.
43. Walsh EJ, Miajlovic H, Gorkun OV, Foster TJ. Identification of the Staphylococcus aureus MSCRAMM clumping factor B (ClfB) binding site in the alphaC-domain of human fibrinogen. Microbiology. 2008 Feb;154(Pt 2):550-8.
44. Walsh EJ, O'Brien LM, Liang X, Hook M, Foster TJ. Clumping factor B, a fibrinogen-binding MSCRAMM (microbial surface components recognizing adhesive matrix molecules) adhesin of Staphylococcus aureus, also binds to the tail region of type I cytokeratin 10. J Biol Chem. 2004 Dec 3;279(49):50691-9.
45. Jongerius I, Köhl J, Pandey MK, Ruyken M, van Kessel KP, van Strijp JA, Rooijakkers SH. Staphylococcal complement evasion by various convertase-blocking molecules. J Exp Med. 2007 Oct 1;204(10):2461-71. Epub 2007 Sep 24.
46. van Wamel WJ, Rooijakkers SH, Ruyken M, van Kessel KP, van Strijp JA. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin- converting bacteriophages. J Bacteriol. 2006 Feb;188(4):1310-15.
47. Otto M. Targeted immunotherapy for staphylococcal infections: focus on anti-MSCRAMM antibodies. BioDrugs. 2008;22(1):27-36.
48. Smyth DS, Feil EJ, Meaney WJ, Hartigan PJ, Tollersrud T, Fitzgerald JR, Enright MC, Smyth CJ. Molecular genetic typing reveals further insights into the diversity of animal-associated Staphylococcus aureus. J Med Microbiol. 2009 Oct;58(Pt 10):1343-53.
49. Sytnik SI. Antagonistic action of corynebacteria and bacilli of a skin ecotype on staphylococci. Mikrobiol Zh. 1989 Jan-Feb;51(1):82-7.
50. Bogaert D, van Belkum A, Sluijter M, Luijendijk A, de Groot R, Rümke HC, Verbrugh HA, Hermans PW. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet. 2004 Jun 5;363(9424):1871-2.
51. Lowe AM, Beattie DT, Deresiewicz RL. Identification of novel staphylococcal virulence genes by in vivo expression technology. Mol Microbiol. 1998 Mar;27(5): 967-76.
52. Lebon A, Labout JA, Verbrugh HA, Jaddoe VW, Hofman A, van Wamel WJ, van Belkum A, Moll HA. Role of Staphylococcus aureus nasal colonization in atopic dermatitis in infants: the Generation R Study. Arch Pediatr Adolesc Med. 2009 Aug;163(8):745-9.
53. Lebon A, Labout JA, Verbrugh HA, Jaddoe VW, Hofman A, van Wamel W, Moll HA, van Belkum A. Dynamics and determinants of Staphylococcus aureus carriage in infancy: the Generation R Study. J Clin Microbiol. 2008 Oct;46(10):3517-21.
54. Jaddoe VW, van Duijn CM, van der Heijden AJ, Mackenbach JP, Moll HA, Steegers EA, Tiemeier H, Uitterlinden AG, Verhulst FC, Hofman A. The Generation R Study: design and cohort update until the age of 4 years. Eur J Epidemiol. 2008;23(12):801-11.
55. Labout JA, Duijts L, Arends LR, Jaddoe VW, Hofman A, de Groot R, Verbrugh HA, Hermans PW, Moll HA. Factors associated with pneumococcal carriage in healthy Dutch infants: the generation R study. J Pediatr. 2008 Dec;153(6):771-6.
56. Regev-Yochay G, Trzcinski K, Thompson CM, Malley R, Lipsitch M. Interference between Streptococcus pneumoniae and Staphylococcus aureus: In vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae. J Bacteriol. 2006 Jul;188(13):4996-5001.
57. Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 2009 May;123(5):e808-e14.
58. Tempelmans Plat-Sinnige MJ, Verkaik NJ, van Wamel WJ, de Groot N, Acton DS, van Belkum A. Induction of Staphylococcus aureus-specific IgA and agglutination potency in milk of cows by mucosal immunization. Vaccine. 2009 Jun 19;27(30):4001-09. Epub 2009 May 3.
59. Seideman J, Peritt D. A novel monoclonal antibody screening method using the Luminex-100 microsphere system. J Immunol Methods. 2002 Sep 15;267(2):165-71.
60. Verkaik NJ, Brouwer E, Hooijkaas H, van Belkum A, vanWamelW. Comparison of carboxylated and Penta-His microspheres for semi-quantitative measurement of antibody responses to His-tagged proteins. J Immunol Methods. 2008 Jun 1;335(1-2):121-5.
61. Verkaik NJ, Dauwalder O, Boubakri K, de Vogel CP, Badiou C, Bes M, Vandenesch F, Tazir M, Hooijkaas H, Verbrugh HA, van Belkum A, Etienne J, Lina G, Ramdani-Bouguessa N, van Wamel WJB. Immunogenicity of toxins during Staphylococcus aureus infections. Clin Infect Dis. 2010 Jan 1;50(1):61-8.
62. Verkaik NJ, de Vogel CP, Boelens HA, Grumann D, Hoogenboezem T, Vink C, Hooijkaas H, Foster TJ, Verbrugh HA, van Belkum A, van Wamel WJB. Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. J Infect Dis 2009 Mar 1;199(5):625-32.
63. Verkaik NJ, Lebon A, de Vogel CP, Hooijkaas H, Vebrugh HA, Jaddoe VWV, Hofman A, Moll HA, van Belkum A, van Wamel WJB. Induction of antistaphylococcal antibodies by Staphylococcus aureus nasal colonisation in young children. Clin Microbiol Infect. 2010 Aug;16(8):1312-7.
64. VosMC, Behrendt MD,Melles DC, Mollema FP, de GrootW, Parlevliet G, Ott A, Horst-Kreft D, van Belkum A, Verbrugh HA. 5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands. Infect Control Hosp Epidemiol. 2009 Oct;30(10):977-84.